C-reactive protein levels significantly decreased from baseline to discharge and 1 month later in placebo and atorvastatin groups ( both P < .0001 ) ; however , the reduction was greater in the atorvastatin group ( 62 % vs 11 % at discharge [ P < .0001 ] ; 84 % vs 30 % at 1 month [ P < .0001 ] ) .
